 |
 |
| DISSS Home | Contact Us |
| ||||||||
|
|
|
|
|
|
| ||
|
|
| ||||||
.gif){kind=spacer} 
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||
|
| ||||||||||||||||||||||||||||||||||||
General
Bayer R, Fairchild AL. Public health: surveillance and privacy. Science 2000;290:1898-9.
CDC. Case definitions for infectious conditions under public health surveillance. MMWR 1997;46(No. RR-10). Additional information available at http://www.cdc.gov/ncphi/disss/casedef/index.htm.
CDC. Demographic differences in notifiable infectious disease morbidity-- United States , 1992-1994. MMWR 1997;46:637-41.
CDC. Framework for evaluating public health surveillance systems for early detection of outbreaks; recommendations from the CDC working group. MMWR 2004;53(No.. RR-5):1-13.
CDC. Framework for program evaluation in public health. MMWR 1999;48(No. RR-11).
CDC. Historical perspectives: notifiable disease surveillance and notifiable disease statistics--United States, June 1946 and June 1996. MMWR 1996;45:530-6.
CDC. Manual of procedures for the reporting of nationally notifiable diseases to CDC. Atlanta, GA: US Department of Health and Human Services, Public Health Service, CDC; 1995.
CDC. Manual for the surveillance of vaccine-preventable diseases. Atlanta, GA: US Department of Health and Human Services, Public Health Service, CDC; 1999. Available at http://www.cdc.gov/nip/publications/surv-manual/default.htm.
CDC. National Electronic Disease Surveillance System (NEDSS): a standards-based approach to connect public health and clinical medicine. Journal of Public Health Management and Practice 2001; 7:43 -50.
CDC. Reporting race and ethnicity data--National Electronic Telecommunications System for Surveillance, 1994-1997. MMWR 1999;48:305-12.
CDC. Sexually transmitted disease surveillance 1998. Atlanta: US Department of Health and Human Services, Public Health Service, CDC; 1999.
CDC. Ten leading nationally notifiable infectious diseases-- United States , 1995. MMWR 1996;45:883-4.
CDC. Updated guidelines for evaluating public health surveillance systems: recommendations from the guidelines working group. MMWR 2001;50(No. RR-13):1-36.
CDC. Use of race and ethnicity in public health surveillance: summary of the CDC/ATSDR workshop. MMWR 1993;42(No. RR-10).
Chang M-H, Glynn MK, Groseclose SL. Endemic, notifiable bioterrorism-related diseases, United States, 1992-1999. Emerg Infect Dis 2003;9:556-64.
Chin JE, ed. Control of communicable diseases manual. 17th ed. Washington, DC: American Public Health Association; 2000.
Doyle TJ, Glynn MK, Groseclose SL. Completeness of notifiable infectious disease reporting in the United States : an analytical literature review. Am J Epidemiol 2002;155:866-74.
Effler P, Ching-Lee M, Bogard A, Ieong M-C, Nekomoto T, Jernigan D. Statewide system of electronic notifiable disease reporting from clinical laboratories: comparing automated reporting with conventional methods. JAMA 1999;282;1845-50.
Freimuth V, Linnan HW, Potter P. Communicating the threat of emerging infections to the public. Emerg Infect Dis 2000;6:337-47.
Government Accountability Office. Emerging infectious diseases: review of state and federal surveillance efforts. Washington, DC: Government Accountability Office. GAO-04-877; 2004. Available at http://www.gao.gov/new.items/d04877.pdf.
Jajosky RA, Groseclose SL. Evaluation of reporting timeliness of public health surveillance systems for infectious diseases. BMC Public Health 2004; 4:29 .
Koo D, Caldwell B. The role of providers and health plans in infectious disease surveillance. Eff Clin Pract 1999;2:247-52. Available at http://www.acponline.org/journals/ecp/sepoct99/koo.htm.
Koo D, Wetterhall S. History and current status of the National Notifiable Diseases Surveillance System. Journal of Public Health Management and Practice 1996;2:4-10.
Lin SS, Kelsey JL. Use of race and ethnicity in epidemiologic research: concepts, methodological issues, and suggestions for research. Epidemiol Rev 2000;22:187-202.
Martin SM, Bean NH. Data management issues for emerging diseases and new tools for managing surveillance and laboratory data. Emerg Infect Dis 1995;1:124-8. Available at http://www.cdc.gov/ncidod/eid/vol1no4/martin2.htm#top.
Niskar AS, Koo D. Differences in notifiable infectious disease morbidity among adult women--United States, 1992-1994. J Womens Health 1998;7:451-8.
Panackal AA, M’ikanatha NM , Tsui FC, et al. Automatic electronic laboratory-based reporting of notifiable infectious diseases at a large health system. Emerg Infect Dis 2002;8:685-91.
Pinner RW, Koo D, Berkelman RL. Surveillance of infectious diseases. In: Lederberg J, Alexander M, Bloom RB, eds. Encyclopedia of microbiology. 2nd ed. San Diego , CA : Academic Press; 2000;4:506-25.
Pinner RW, Jernigan DB, Sutliff SM. Electronic laboratory-based reporting for public health. Military Medicine 2000;165(suppl 2):20-4.
Roush S, Birkhead G, Koo D, Cobb A, Fleming D. Mandatory reporting of diseases and conditions by health care professionals and laboratories. JAMA 1999;282:164-70. Available at http://jama.ama-assn.org/issues/v282n2/abs/joc90413.html.
Teutsch SM, Churchill RE, eds. Principles and practice of public health surveillance. 2nd ed. New York, NY: Oxford University Press; 2000.
Thacker SB, Choi K, Brachman PS. The surveillance of infectious diseases. JAMA 1983;249:1181-5.
AIDS
CDC. Cases of HIV infection and AIDS in the United States, 2002 HIV/AIDS surveillance report, Vol.14. Atlanta, GA: US Department of Health and Human Services, CDC; 2004. Available at: http://www.cdc.gov/hiv/stats/hasr1402.htm.
CDC. Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. MMWR 1999;48(No. RR-13):1-31.
Nakashima AK, Fleming PL. HIV/AIDS surveillance in the United States, 1981-2001. J Acquir Immune Defic Syndr 2003;32:68-85.
Botulism
Sobel J, Tucker N, MacLaughlin J, Maslanka S. Foodborne botulism in the United States, 1999-2000. Emerg Infect Dis 2004;10:1606-12. Available at http://www.cdc.gov/ncidod/EID/vol10no9/03-0745.htm.
CDC. Botulism in the United States, 1899-1996: handbook for epidemiologists, clinicians and laboratory workers. Atlanta, GA: US Department of Health and Services, CDC; 1998.
Shapiro R, Hatheway C, Swerdlow DL. Botulism in the United States: a clinical and epidemiologic review. Ann Intern Med 1998;129:221-8.
Brucellosis
CDC. Brucellosis: (Brucella melitensis, abortus, suis, and canis). Atlanta, GA: US Department of Health and Human Services, CDC. Available at http://www.cdc.gov/ncidod/dbmd/diseaseinfo/brucellosis_g.htm.
CDC. Brucellosis case definition. Atlanta, GA: US Department of Health and Human Services, CDC; 2001. Available at http://www.bt.cdc.gov/Agent/Brucellosis/CaseDef.asp.
CDC. Human exposure to Brucella abortus strain RB51--Kansas, 1997. MMWR 1998;47:172-5.
Stevens, MG, Olsen SC, Palmer MV, Cheville NF. US Department of Agriculture, Agricultural Research Service National Animal Disease Center, Iowa State University. Brucella abortus strain RB51: a new brucellosis vaccine for cattle. Compendium 1997;19:766-74.
Robichaud S, Libman M, Behr M, Rubin E. Prevention of laboratory-acquired brucellosis. Clin Infect Dis 2004;38:e119-22.
Chomel BB, DeBess EE, Mangiamele DM, et al. Changing trends in the epidemiology of human brucellosis in California from 1973 to 1992: a shift toward foodborne transmission. J Infect Dis 1994;170:1216-23.
Chancroid
DiCarlo RP, Armentor BS, Martin DH. Chancroid epidemiology in New Orleans men. J Infect Dis 1995;172:446-52.
Mertz, KJ, Weiss JB, Webb RM, et al. An investigation of genital ulcers in Jackson, Mississippi, with use of a multiplex polymerase chain reaction assay: high prevalence of chancroid and human immunodeficiency virus infection. J Infect Dis 1998;178:1060-6.
Mertz KJ, Trees D, Levine WC, et al. Etiology of genital ulcers and prevalence of human immunodeficiency virus coinfection in 10 US cities. The Genital Ulcer Disease Surveillance Group. J Infect Dis 1998;178:1795-8.
Chlamydia trachomatis , Genital Infection
CDC. Sexually transmitted disease surveillance 2002 supplement: Chlamydia Prevalence Monitoring Project, annual report 2002. Atlanta, GA: US Department of Health and Human Services, CDC; 2003. Available at http://www.cdc.gov/std/chlamydia2002.
Gaydos CA, Howell MR, Pare B, et al. Chlamydia trachomatis infections in female military recruits. N Engl J Med 1998;339:739-44.
Mertz KJ, McQuillian GM, Levine WC, et al. A pilot study of chlamydial infection in a national household survey. Sex Transm Dis 1998;25:225-8.
Miller WC, Ford CA, Handcock MS, et al. Prevalance of chlamydial and gonococcal infections among young adults in the United States. JAMA 2004;291:2229-36.
Cholera
Steinberg EB, Greene KD, Bopp CA, Cameron DN, Wells JG, Mintz ED. Cholera in the United States, 1995-2000: Trends at the end of the millennium. J Infect Dis 2001;184,799-802.
World Health Organization. Cholera, 2003. Wkly Epidemiol Rec 2004;31:281-8.
Mintz ED, Tauxe RV, Levine MM. The global resurgence of cholera. In: Noah ND, O’Mahony M, eds. Communicable disease epidemiology and control. Chichester, England: John Wiley & Sons; 1998:63-104.
Mahon BE, Mintz ED, Greene KD, Wells JG, Tauxe RV. Reported cholera in the United Sates, 1992-1994: a reflection of global change in cholera epidemiology. JAMA 1996;276:307-12.
Cryptosporidiosis
Roy SL, DeLong SM, Stenzel SA, et al. Risk factors for sporadic cryptosporidiosis among immunocompetent persons in the United States from 1999 to 2001. J Clin Microbiol 2004;42:2944-51.
CDC. Diagnostic procedures for stool specimens: detection of parasite antigens. Atlanta, GA: US Department of Health and Human Services, CDC. Available at http://www.dpd.cdc.gov/DPDx/HTML/DiagnosticProcedures.htm.
Yoder JS, Blackburn BG, Craun GF, et al. Surveillance for waterborne-disease outbreaks associated with recreational water--United States, 2001-2002. In: Surveillance Summaries, October 22, 2004. MMWR 2002:53(No. SS-8): 1-21.
Rose JB, Huffman DE, Gennaccaro A. Risk and control of waterborne cryptosporidiosis. FEMS Microbiol Rev 2002;26:113-23.
Cyclosporiasis
Lopez AS, Bendik JM, Alliance JY, et al. Epidemiology of Cyclospora cayetanensis and other intestinal parasites in a community in Haiti. J Clin Microbiol 2003;41:2047-54.
Ho AY, Lopez AS, Eberhard MG, et al. Outbreak of cyclosporiasis associated with imported raspberries, Philadelphia, Pennsylvania, 2000. Emerg Infect Dis 2002;8:783-8.
Herwaldt BL. Cyclospora cayetanensis: a review, focusing on the outbreaks of cyclosporiasis in the 1990s. Clin Infect Dis 2000;31:1040-57.
Ehrlichiosis (Human Granulocytic and Human Monocytic)
Ehrlichia chafeensis: a prototypical emerging pathogen [Review]. Paddock CD, Childs JE. J Clin Microbiol 2003; 16:37-64.
IJdo JW, Meek JI, Cartter ML, et al. The emergence of another tickborne infection in the 12-town area around Lyme, Connecticut: human granulocytic ehrlichiosis. J Infect Dis 2000;181:1388-93.
McQuiston JH, Paddock CD, Holman RC, Childs JE. The human ehrlichioses in the United States [Review]. Emerg Infect Dis 1999;5:635-42. Available at http://www.cdc.gov/ncidod/eid/vol5no5/mcquiston.htm.
Childs JE, Sumner JW, Nicholson WL, Massung RF, Standaert SM, Paddock CD. Outcome of diagnostic tests using samples from patients with culture-proven human monocytic ehrlichiosis: implications for surveillance. J Clin Microbiol 1999;37:2997-3000.
Giardiasis
Stuart JM, Orr HJ, Warburton FG, et al. Risk factors for sporadic giardiasis: a case-control study in Southwestern England. Emerg Infect Dis 2003;9:229-33.
CDC. Diagnostic procedures for stool specimens: detection of parasite antigens. Atlanta, GA: US Department of Health and Human Services, CDC; 2004. Available at http://www.dpd.cdc.gov/DPDx/HTML/DiagnosticProcedures.htm.
Blackburn BG, Craun GF, Yoder JS, et al. Surveillance for waterborne-disease outbreaks associated with drinking water--United States, 2001-2002. In: Surveillance Summaries, October 22, 2004. MMWR 2002:53(No. SS-8):23-45.
Furness BW, Beach MJ, Roberts JM. Giardiasis surveillance-- United States, 1992-1997. In: CDC Surveillance Summaries, August 11, 2000. MMWR 2000:49(No. SS-7):1-13.
Gonorrhea
CDC. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae among men who have sex with men-- United States, 2003, and revised recommendations for gonorrhea treatment, 2004. MMWR 2004;53:335-8.
CDC. Sexually transmitted diseases treatment guidelines, 2002. MMWR 2002;51(No. RR-6).
CDC. Sexually transmitted diseases surveillance 2002 supplement: Gonococcal Isolate Surveillance Project (GISP) annual report 2002. Atlanta, GA: US Department of Health and Human Services, CDC; 2003.
Fox KK, del Rio C, Holmes KK, et al. Gonorrhea in the HIV era: a reversal in trends among men who have sex with men. Am J Public Health 2001;91:959-64.
Haemophilus influenzae , Invasive Disease
LaClaire LL, Tondella ML, Beall DS et al. Identification of Haemophilus influenzae serotypes by standard slide agglutination serotyping and PCR-based capsule typing. J Clin Micro 2003;41:393-6.
CDC. Progress toward elimination of Haemophilus influenzae type b disease among infants and children-- United States, 1998-2000. MMWR 2002;51:234-7.
Fry AM, Lurie P, Gidley M, Schmink S, Lingappa J, Rosenstein NE. Haemophilus influenzae type b (Hib) disease among Amish children in Pennsylvania: reasons for persistent disease. Pediatrics 2001;108:1-6.
CDC. Recommendations for use of Haemophilus b conjugate vaccines and a combined diphtheria, tetanus, pertussis, and Haemophilus b vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1993;42(No. RR-13).
Hepatitis A
Armstrong GL, Bell BP. Hepatitis A virus infections in the United States: model-based estimates and implications for childhood immunization. Pediatrics 2002;109:839-45.
CDC. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999;48(No. RR-12).
Bell BP, Shapiro CN, Alter MJ, et al. The diverse patterns of hepatitis A epidemiology in the United States--implications for vaccination strategies. J Infect Dis 1998;178:1579-84.
Lemon SM, Shapiro CN. The value of immunization against hepatitis A. Infect Agents Dis 1994; 3:38-49.
Shapiro CN, Coleman PJ, McQuillan GM, Alter MJ, Margolis HS. Epidemiology of hepatitis A: seroepidemiology and risk groups in the USA. Vaccine 1992;10(suppl 1):S59-62.
Hepatitis B
Coleman PJ, McQuillan GM, Moyer LA, Lambert SB, Margolis HS. Incidence of hepatitis B virus infection in the United States, 1976-1994: estimates from the National Health and Nutrition Examination Surveys. J Infect Dis 1998;178:954-9.
CDC. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991;40(No. RR-13):1-19.
Goldstein ST, Alter MJ, Williams IT, et al. Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs. J Infect Dis 2002;185:713-9.
McQuillan GM, Coleman PJ, Kruszon-Moran D, Moyer LA, Lambert SB, Margolis HS. Prevalence of hepatitis B virus infection in the United States: The National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health 1999;89:14-8.
Margolis HS, Alter MJ, Hadler SC. Hepatitis B: evolving epidemiology and implications for control [Review]. Semin Liver Dis 1991;11:84-92.
Hepatitis C
Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-62.
Armstrong GA, Alter MJ, McQuillan GM, Margolis HS. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology 2000;31:777-82.
CDC. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 1998;47(No. RR-19).
Lyme Disease
Stafford KC III. Tick management handbook: a integrated guide for homeowners, pest control operators, and public health officials for the prevention of tick-associated disease. Connecticut Agricultural Experiment Station; 2004. Available at http://www.caes.state.ct.us/SpecialFeatures/TickHandbook.pdf.
Hayes EB, Piesman J. How can we prevent Lyme disease? N Eng J Med 2003;348:2424-30.
Bunikis J, Barbour AG. Laboratory testing for suspected Lyme disease. Med Clin North Am 2002;86:311-40.
Guerra M, Walker E, Jone C, et al. Predicting risk of Lyme disease: habitat suitability for Ixodes scapularis in the North Central United States. Emerg Infect Dis 2002;8:289-97.
Malaria
CDC. Malaria surveillance-- United States, 2002. In: Surveillance Summaries, April 30, 2004. MMWR 2004;53(No. SS-1):21-34.
CDC. Probable transfusion-transmitted malaria-- Houston, Texas, 2003. MMWR 2003;52:1075-6.
CDC. Local transmission of Plasmodium vivax malaria-- Palm Beach County, Florida, 2003. MMWR 2003;52:908-11.
Lobel HO, Kozarsky PE. Update on prevention of malaria for travelers. JAMA 1997;278:1767-71.
Measles
Papania M, Hinman A, Katz S, Orenstein W, McCauley M, eds. Progress toward measles elimination--absence of measles as an endemic disease in the United States. J Infect Dis 2004;189(Suppl 1):S1-257.
CDC. National, state, and urban area vaccination levels among children aged 19-35 months--United States, 2002. MMWR 2003;52:728-32.
Rota PA, Liffick SL, Rota JS, et al. Molecular epidemiology of measles viruses in the United States, 1997-2001. Emerg Infect Dis 2002;8:902-8.
De Serres G, Gay NJ, Farrington CP. Epidemiology of transmissible diseases after elimination. Am J Epidemiol 2000;151:1039-48.
Plague
CDC. Imported plague-- New York City, 2002. MMWR 2003;53:725-8.
Enscore RE, Biggerstaff BJ, Brown TL, et al. Modeling relationships between climate and the frequency of human plague cases in the southwestern United States, 1960-1997. Am J Trop Med Hyg 2002;66:186-96.
Inglesby TV, Dennis DT, Henderson DA, et al. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense [Review]. JAMA 2000;283:2281-90.
Dennis DT, Gage KL, Gratz N, Poland JD, Tikhomirov E. Plague manual: epidemiology, distribution, surveillance and control. Geneva, Switzerland: World Health Organization; 1999.
Rubella
CDC. Control and prevention of rubella: evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. MMWR 2001;50(No. RR-12).
Danovaro-Holliday MC, Gordon E, Woernle C, et al. Identifying risk factors for rubella susceptibility in a population at risk in the United States. Am J Public Health 2003;93:289-91.
Reef SE, Frey TK, Theall K, et al. The changing epidemiology of rubella in the 1990s: on the verge of elimination and new challenges for control and prevention. JAMA 2002;287;464-72.
Reef S, Plotkin S, Cordero J, et al. Preparing for congenital rubella syndrome elimination: summary of the Workshop on Congenital Rubella Elimination in the United States. Clin Infect Dis 2000;31:85-95.
Q Fever
McQuiston JH, Childs JE. Q fever in humans and animals in the United States [Review]. Vector Borne and Zoonotic Dis 2002;179-191.
CDC. Q Fever-- California, Georgia, Pennsylvania, and Tennessee, 2000-2001. MMWR 2002;51:924-7.
Raoult D, Tissot-Dupont H, Foucault C, et al. Q fever 1985-1998. Clinical and epidemiologic features of 1,383 infections [Review]. Medicine 2000:79:109-25.
Bernard KW, Parham GL, Winkler WG, Helmick CG. Q fever control measures: recommendations for research facilities using sheep. Infection Control 1982;3:461-65.
Rabies, Animal and Human
CDC. Compendium of animal rabies prevention and control, 2004: National Association of State and Territorial Public Health Veterinarians, Inc. MMWR 2004;53(No.RR-9).
CDC. Human rabies prevention--United States, 1999: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999;48(No. RR-1).
Krebs J.W., J.T. Wheeling, J.E. Childs. 2003. Rabies surveillance in the United States during 2002. J. Am Vet Med Assoc 223:1736-8.
Noah DL, Drenzek CL, Smith JS, et al. Epidemiology of human rabies in the United States, 1980 to 1996 [Review]. Ann Intern Med 1998;128:922-0.
Rocky Mountain Spotted Fever
Cases of Rocky Mountain spotted fever in family clusters--three states, 2003. MMWR 2004:53:407-10.
Treadwell TA, Holman RC, Clarke MA et al. Rocky Mountain spotted fever in the United States, 1993-1996. Am J Trop Med Hyg 2000;63:21-6.
Thorner AR, Walker, DH, Petri WA. Rocky Mountain spotted fever [Review]. Clin Infect Dis 1998;27:1353-60.
Dalton MJ, Clarke MJ, Holman RC, et al. National surveillance for Rocky Mountain spotted fever, 1981-1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg 1995;52:405-13.
Shigellosis
Gupta A, Polyak CS, Bishop RD, Sobel J, Mintz ED. Laboratory-confirmed shigellosis in the United States, 1989-2002: epidemiologic trends and patterns. Clin Infect Dis 2004;38:1372-7.
Kalluri P, Cummings K, Abbott S, et al. Epidemiological features of a newly described serotype of Shigella boydii. Epidemiol Infect 2004;132;579-83.
Shane A, Crump J, Tucker N, Painter J, Mintz E. Sharing Shigella: risk factors and costs of a multi-community outbreak of shigellosis. Arch Pediatrics and Adolescent Medicine 2003;157:601-3.
Naimi TS, Wicklund JH, Olsen SJ et al. Concurrent outbreaks of Shigella sonnei and enterotoxigenic Escherichia coli infections associated with parsley: implications for surveillance and outbreak control. Journal of Food Protection 2003;66:535-41.
Streptococcal Disease, Invasive, Group A
The Prevention of Invasive Group A Streptococcal Infections Workshop Participants. Prevention of invasive group A streptococcal disease among household contacts of case patients and among postpartum and postsurgical patients: recommendations from the Centers for Disease Control and Prevention. Clin Infect Dis 2002;35:950-9.
CDC. Active Bacterial Core Surveillance report. Emerging Infections Program Network. Group A streptococcus, 2003--preliminary. Atlanta, GA: Available at http://www.cdc.gov/ncidod/dbmd/abcs/survreports/gas03prelim.pdf.
O’Brien KL, Beall B, Barrett NL, et al. Epidemiology of invasive group A streptococcus disease in the United States, 1995-1999. Clin Infect Dis 2002;35:268-76.
Factor SH, Levine OS, Schwartz B, et al. Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis 2003;9:970-7.
Streptococcus pneumoniae , Invasive, Drug-Resistant
CDC. Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices. MMWR 2000;49 (No. RR-9):1-38.
Flannery B, Schrag S, Bennett NM, et al. Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumonias infections in the United States, 1998-2002. JAMA 2004;291:2197-2203.
Whitney CG, Farley MM, Hadler J, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 2000;343:1917-24.
Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease following the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003; 348:1737-46.
Syphilis, Congenital
CDC. Congenital syphilis-- United States , 2002. MMWR 2004;53:716-9.
Syphilis, Primary and Secondary
CDC. The national plan to eliminate syphilis from the United States. Atlanta, GA: US Department of Health and Human Services, CDC; 1999.
CDC. Trends in primary and secondary syphilis and HIV infections in men who have sex with men-- San Francisco and Los Angeles, California, 1998-2002. MMWR 2004;53:575-8.
CDC. Primary and secondary syphilis-- United States, 2002. MMWR 2003;52:1117-20.
CDC. Sexually transmitted disease surveillance supplement 2002: syphilis surveillance report. Atlanta, GA: US Department of Health and Human Services, CDC; 2004.
Tetanus
Pascual FB, McGinley EL, Zanardi LR, Cortese MM, Murphy TV. Tetanus surveillance-- United States, 1998-2000. In: Surveillance Summaries, June 20, 2003. MMWR 2003;52(No. SS-3):1-8.
CDC. Tetanus-- Puerto Rico, 2002. MMWR 2002;51:613-5.
Fair E, Murphy T, Golaz A, Wharton M. Philosophic objection to vaccination as a risk for tetanus among children <15 years of age. Pediatrics 2002;109:E2.
McQuillan GM, Kruszon-Moran D, Deforest A, Chu SY, Wharton M. Serologic immunity to diphtheria and tetanus in the United States. Ann Intern Med 2002;136:660-6.
Trichinellosis
CDC. Trichinellosis associated with bear meat--New York and Tennessee, 2003. MMWR 2004;53:606-10.
Roy SL, Lopez AS, Schantz PM. Trichinellosis surveillance-- United States, 1997-2001. In: Surveillance Summaries, July 25, 2003. MMWR 2003;52(No.SS-6):1-8.
Moorhead A, Grunenwald PE, Dietz VJ, Schantz PM. Trichinellosis in the United States, 1991-1996: declining but not gone. Am J Trop Med Hyg 1999;60:66-9.
CDC. Outbreak of trichinellosis associated with eating cougar jerky--Idaho, 1995. MMWR 1996;45:205-6.
Tuberculosis
CDC. Reported tuberculosis in the United States, 2003. Atlanta, GA: US Department of Health and Human Services, CDC; 2004. Available at http://www.cdc.gov/nchstp/tb.
CDC. Trends in tuberculosis morbidity-- United States, 1998-2003. MMWR 2004;53:209-14.
Saraiya M, Cookson ST, Tribble P, et al. Tuberculosis screening among foreign-born persons applying for permanent US residence. Am J Public Health 2002;92:826-9.
Talbot EA, Moore M, McCray E, Binkin NJ. Tuberculosis among foreign-born persons in the United States, 1993-1998. JAMA 2000;284:2894-900.
Tularemia
CDC. Outbreak of tularemia among commercially distributed prairie dogs, 2002. MMWR 2002;51:688,699.
CDC. Tularemia-- United States, 1990-2000. MMWR 2002;51:182-4.
Dennis DT, Inglesby TV, Henderson DA, et al. Tularemia as a biological weapon: medical and public health management. JAMA 2001;285:2763-73.
Feldman KA, Enscore RE, Lathrop SL, et al. Outbreak of primary pneumonic tularemia on Martha’s Vineyard. N Engl J Med 2001:345:1219-26.
Typhoid Fever
Steinberg EB, Bishop RB, Dempsey AF, et al. Typhoid fever in travelers: who should be targeted for prevention? Clin Infect Dis 2004;39:186-91.
Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull WHO 2004;84:346-53.
Olsen SJ, Bleasdale SC, Magnano AR, et al. Outbreaks of typhoid fever in the United States, 1960-1999. Epidemiol Infect 2003;130:13-21.
Reller M, Olsen S, Kressel A. Sexual transmission of typhoid fever: a multi-state outbreak among men who have sex with men. Clin Infect Dis 2003;37:141-4.
Varicella
Seward JF, Zhang JX, Maupin TJ, Mascola L, Jumaan AO. Contagiousness of varicella in vaccinated cases: a household contact study. JAMA 2004;292:704-8.
CDC. Outbreak of varicella among vaccinated children-- Michigan, 2003. MMWR 2004;53:389-92.
CDC. Prevention of varicella: updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999;48(No. RR-6).
CDC. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1996;45(No. RR-11):1-25.
 |
|
|
|
|
Privacy Policy | Accessibility CDC Home | Search | Health Topics A-Z This page last updated January 9, 2008 United States
Department of Health and Human Services "Epi Info" is a trademark of the Centers for Disease Control and Prevention (CDC). |
